ESPR vs ISRG · rev $332.3M vs P/E 80, rev $2.89B
Esperion Therapeutics Inc (ESPR) versus Intuitive Surgical Inc (ISRG) — a side-by-side from cached financials, not a winner call.
Esperion Therapeutics Inc (ESPR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Intuitive Surgical Inc (ISRG) is a medical instruments & supplies company listed on US.
Latest reported ESPR revenue for 2024-12-31 was $332.3M. Net income was -$51.7M. Revenue was up 185.7% from 2023-12-31 to 2024-12-31. ESPR currently screens at market cap $816.9M.
Latest reported ISRG revenue for 2026-06-30 was $2.89B. Net income was $818.1M. Revenue was up 4.4% from 2026-03-31 to 2026-06-30. ISRG currently screens at market cap $195.15B and trailing P/E 80.0.
ESPR currently screens at market cap $816.9M. ISRG currently screens at market cap $195.15B and trailing P/E 80.0.
Not investment advice. Open the ESPR and ISRG stock pages for the full models.
Not investment advice.